4D Medicine Submits Q-Sub for Peripheral Nerve Protector
4D Medicine has submitted a Q-Submission (Q-Sub) to the U.S. Food and Drug Administration (FDA) for its Peripheral Nerve Protector, in preparation for a planned 510(k) submission later this year.
This important step enables early engagement with the FDA to align on regulatory strategy, supporting efficient progression toward future clinical and commercial milestones.
